Pluxee Stock Rises 2% Marking Nearly 20% Gain Over a Month
The employee benefits specialist continues its ascent on the Paris Stock Exchange, bucking the trend of a declining CAC 40. The session extends a catch-up movement that began in mid-June and is accompanied by a new stance from a major international broker.
A Rebound that Widens the Gap with the Three Moving Averages
Pluxee's stock advanced by 2.09% to €13.67 mid-morning, while the SBF 120 dropped by 0.45% and the CAC 40 fell by 0.42%. The stock is among the top gainers in the SBF 120, now showing a gain of 19.7% over the month and 11.05% over the week, contrasting with a still-near 25% annual decline. Today's movement further distances the price from its three moving averages, which have been successively crossed since the end of June.
The MM20 (€11.98) and MM50 (€11.81) are respectively 14.1% and 15.7% below the current price, while the MM200 (€12.49) remains 9.5% beneath. The RSI at 69 is approaching the overbought threshold without crossing it, following a sustained bullish movement since the third-quarter revenue announcement on July 3.
Morgan Stanley Initiates Coverage with a Target of €15.50
Morgan Stanley initiated coverage yesterday with an 'equal-weight' rating and a price target of €15.50, representing a potential upside of about 13% from the current price. This position is the first recorded since the technical rebound of the stock and comes as the consensus among analysts values the company at around 9 times the expected earnings for the current and following fiscal year. During the Q3 2026 announcement on July 3, the management confirmed its annual financial targets despite a 3.3% decline in quarterly revenue, hindered by regulatory reform in Brazil and a deteriorated macroeconomic environment in continental Europe.
The cumulative organic growth over nine months remains positive at 2.7%.
